Iguratimod for the treatment of rheumatoid arthritis in Japan

@article{Tanaka2015IguratimodFT,
  title={Iguratimod for the treatment of rheumatoid arthritis in Japan},
  author={K. Tanaka and Tomonobu Yamaguchi and M. Hara},
  journal={Expert Review of Clinical Immunology},
  year={2015},
  volume={11},
  pages={565 - 573}
}
  • K. Tanaka, Tomonobu Yamaguchi, M. Hara
  • Published 2015
  • Medicine
  • Expert Review of Clinical Immunology
  • Iguratimod (IGU), a small-molecule compound, was developed as a disease-modifying antirheumatic drug in Japan. The pharmacological studies showed that inhibition of the production of cytokines and immunoglobulins mainly contributes to its improvement effect on animal arthritis models. The first clinical study of IGU in Japanese patients with rheumatoid arthritis was started in 1992 and Phase III studies were started in 1998. From the results of Phase II studies, a dose-escalating regimen was… CONTINUE READING
    24 Citations
    Iguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape
    • 4
    • Highly Influenced
    • PDF
    Molecular mechanisms and clinical application of Iguratimod: A review.
    • 3
    Efficacy and safety of combined etanercept and iguratimod for active rheumatoid arthritis
    Biologics in sjögren's syndrome.
    • 1
    Anti-allodynic action of the disease-modifying anti-rheumatic drug iguratimod in a rat model of neuropathic pain
    • 6
    Sjögren's syndrome: Old and new therapeutic targets.
    • 17

    References

    SHOWING 1-10 OF 48 REFERENCES
    Iguratimod: a new disease-modifying antirheumatic drug.
    • 27
    Efficacy of the clinical use of iguratimod therapy in patients with rheumatoid arthritis
    • 24
    Efficacy and safety of iguratimod compared with placebo and salazosulfapyridine in active rheumatoid arthritis: a controlled, multicenter, double-blind, parallel-group study
    • 68
    • Highly Influential
    Long-term safety study of iguratimod in patients with rheumatoid arthritis
    • 34
    • PDF
    A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis.
    • 418
    • PDF
    Concomitant Leflunomide Therapy in Patients with Active Rheumatoid Arthritis despite Stable Doses of Methotrexate
    • 352